Clinical Trial Update: Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis Vulgaris [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed the effect of LEO 80185 Gel on the HPA axis and calcium metabolism in people with extensive psoriasis vulgaris; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• LEO 80185 Gel

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 2 | Status: COMPLETED